Literature DB >> 8569443

MRI of human tumor xenografts in vivo: proton relaxation times and extracellular tumor volume.

I Jakobsen1, H Lyng, O Kaalhus, E K Rofstad.   

Abstract

Proton T1 and T2 differ substantially between tumors, but the tumor properties causing heterogeneity in T1 and T2 have not been fully recognized. The purpose of the study reported here was to investigate whether differences in T1 and T2 between tumors are mainly a consequence of differences in the fractional volume of the extracellular compartment. The study was performed using a single human tumor xenograft line showing large naturally occurring intratumor heterogeneity in the size of the extracellular compartment. The size of the extracellular compartment was calculated from the volume and the density of the tumor cells. Cell volume was measured by an electronic particle counter. Cell density was determined by stereological analysis of histological preparations. T1 and T2 were measured by MRI in vivo both in the absence and presence of Gd-DTPA. Two spin-echo pulse sequences were used, one with a repetition time (TR) of 600 ms and echo times (TEs) of 20, 40, 60, and 80 ms and the other with a TR of 2,000 ms and TEs of 20, 40, 60, and 80 ms. Measurements of T1 and T2 in the presence of Gd-DTPA were performed in a state of semi-equilibrium between uptake and clearance of Gd-DTPA. MR-images and histological preparations of tumor subregions homogeneous in extracellular volume were analysed in pairs. The extracellular volume differed between tumor subregions from 5 to 70%. T1 and T2 measured in the absence of Gd-DTPA differed between tumor subregions by a factor of approximately 1.5 and increased with increasing extracellular volume. The relative decrease in T1 caused by Gd-DTPA, represented by (T1 control-T1 Gd-DTPA)/T1 control, also increased with increasing extracellular volume.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8569443     DOI: 10.1016/0730-725x(95)00019-d

Source DB:  PubMed          Journal:  Magn Reson Imaging        ISSN: 0730-725X            Impact factor:   2.546


  11 in total

1.  Integration of quantitative DCE-MRI and ADC mapping to monitor treatment response in human breast cancer: initial results.

Authors:  Thomas E Yankeelov; Martin Lepage; Anuradha Chakravarthy; Elizabeth E Broome; Kenneth J Niermann; Mark C Kelley; Ingrid Meszoely; Ingrid A Mayer; Cheryl R Herman; Kevin McManus; Ronald R Price; John C Gore
Journal:  Magn Reson Imaging       Date:  2006-11-21       Impact factor: 2.546

2.  A pre-tracer approach for improving the accuracy of metabolic measurements by hyperpolarized nuclear magnetic resonance.

Authors:  Lin Z Li
Journal:  Quant Imaging Med Surg       Date:  2016-10

3.  Vasculature-specific MRI reveals differential anti-angiogenic effects of a biomimetic peptide in an orthotopic breast cancer model.

Authors:  Eugene Kim; Esak Lee; Charlesa Plummer; Stacy Gil; Aleksander S Popel; Arvind P Pathak
Journal:  Angiogenesis       Date:  2014-11-19       Impact factor: 9.596

4.  Molecular imaging of water binding state and diffusion in breast cancer using diffuse optical spectroscopy and diffusion weighted MRI.

Authors:  So Hyun Chung; Hon Yu; Min-Ying Su; Albert E Cerussi; Bruce J Tromberg
Journal:  J Biomed Opt       Date:  2012-07       Impact factor: 3.170

5.  Microfiberoptic measurement of extracellular space volume in brain and tumor slices based on fluorescent dye partitioning.

Authors:  Hua Zhang; A S Verkman
Journal:  Biophys J       Date:  2010-08-09       Impact factor: 4.033

6.  Evidence of multiexponential T2 in rat glioblastoma.

Authors:  Richard D Dortch; Thomas E Yankeelov; Zoe Yue; Christopher C Quarles; John C Gore; Mark D Does
Journal:  NMR Biomed       Date:  2009-07       Impact factor: 4.044

7.  Tailoring nanoparticle designs to target cancer based on tumor pathophysiology.

Authors:  Edward A Sykes; Qin Dai; Christopher D Sarsons; Juan Chen; Jonathan V Rocheleau; David M Hwang; Gang Zheng; David T Cramb; Kristina D Rinker; Warren C W Chan
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-16       Impact factor: 11.205

8.  Tumor T1 Relaxation Time for Assessing Response to Bevacizumab Anti-Angiogenic Therapy in a Mouse Ovarian Cancer Model.

Authors:  Murali K Ravoori; Masato Nishimura; Sheela P Singh; Chunhua Lu; Lin Han; Brian P Hobbs; Sunila Pradeep; Hyun J Choi; James A Bankson; Anil K Sood; Vikas Kundra
Journal:  PLoS One       Date:  2015-06-22       Impact factor: 3.240

9.  Tumour T1 changes in vivo are highly predictive of response to chemotherapy and reflect the number of viable tumour cells--a preclinical MR study in mice.

Authors:  Claudia Weidensteiner; Peter R Allegrini; Melanie Sticker-Jantscheff; Vincent Romanet; Stephane Ferretti; Paul M J McSheehy
Journal:  BMC Cancer       Date:  2014-02-14       Impact factor: 4.430

10.  Investigating intracranial tumour growth patterns with multiparametric MRI incorporating Gd-DTPA and USPIO-enhanced imaging.

Authors:  Jessica K R Boult; Marco Borri; Alexa Jury; Sergey Popov; Gary Box; Lara Perryman; Suzanne A Eccles; Chris Jones; Simon P Robinson
Journal:  NMR Biomed       Date:  2016-09-27       Impact factor: 4.044

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.